Microwave Ablation of Insulinoma
A. F. Chernousov,
A. V. Egorov,
G. Kh. Musaev,
I. A. Vasil'yev,
V. A. Parnova,
Yu. Yu. Yurichenko,
D. V. Lezhinsky
https://doi.org/10.16931/1995-5464.2016435-40
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
Abstract
Aim: to present the first experience of using of microwave ablation in management of functioning pancreatic neuroendocrine tumors.
Material and Methods. We present treatment of 350 patients with hormone-producing pancreatic tumors. Five of them with symptoms of organic hyperinsulinism underwent microwave ablation (MWA) of tumors.
Results. Sustained remission of clinical manifestations was achieved in all patients with insulinomas after microwave ablation. There were no complications after manipulation in 2 cases. 2 patients had complications Clavien-Dindo degree 1–2, in 1 case readmission was required (Clavien–Dindo degree 3).
Conclusion. The role of microwave ablation in pancreatic neuroendocrine tumors management is not defined. Local destruction is indicated in selected cases, so assessment of large number of cases and long-term outcomes is difficult. However, the microwave ablation allows controlling the symptoms of hormones overexpression in patients with high risk
of postoperative complications
About the Authors
A. F. Chernousov
University's Clinical Hospital №1 of the Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Doct. of Med. Sci., Professor, Academic of Russian Academy of Science, Chief of
N.N. Burdenko Surgical Clinic, Sechenov First Moscow State Medical University
A. V. Egorov
University's Clinical Hospital №1 of the Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Doct. of Med. Sci., Professor, Head of the Surgical Oncology Department, University's Clinical Hospital №1 of Sechenov First Moscow State Medical University
G. Kh. Musaev
University's Clinical Hospital №1 of the Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Doct. of Med. Sci., Professor of the Chair of Faculty Surgery №1, Sechenov First Moscow State Medical University
I. A. Vasil'yev
University's Clinical Hospital №1 of the Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Cand. of Med. Sci., Surgeon at the Surgical Oncology Department, University's Clinical Hospital №1 of Sechenov First Moscow State Medical University
V. A. Parnova
University's Clinical Hospital №1 of the Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Cand. of Med. Sci., Physician at the Endoscopy Department, University's Clinical Hospital №1 of Sechenov First Moscow State Medical University.
Yu. Yu. Yurichenko
University's Clinical Hospital №1 of the Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Surgeon at the Surgical Department, University's Clinical Hospital №1 of Sechenov First Moscow State Medical University
D. V. Lezhinsky
University's Clinical Hospital №1 of the Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Clinical Intern, Chair of Faculty Surgery №1, University's Clinical Hospital №1 of First Moscow State Medical University.
References
1. de Santibañes M., Cristiano A., Mazza O., Grossenbacher L., de Santibañes E., Sánchez Clariá R., Sivori E., García Mónaco R., Pekolj J. Endogenous hyperinsulinemic hypoglycemia syndrome: surgical treatment. Cir. Esp. 2014; 92 (8): 547-552. https://doi.org/10.1016/j.ciresp.2013.04.025. PMID: 24491350.
2. Tsang Y.P., Lang B.H., Shek T.W. Assessing the short- and longterm outcomes after resection of benign insulinoma. ANZ J. Surg. 2014. https://doi.org/10.1111/ans.12891. PMID: 25345822.
3. Crippa S., Zerbi A., Boninsegna L., Capitanio V., Partelli S., Balzano G., Pederzoli P., Di Carlo V., Falconi M. Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. Arch. Surg. 2012; 147 (3): 261-266. https://doi.org/10.1001/archsurg.2011.1843. PMID: 22430908.
4. Varma V., Tariciotti L., Coldham C., Taniere P., Buckels J.A., Bramhall S.R. Preoperative localisation and surgical management of insulinoma: single centre experience. Dig. Surg. 2011; 28 (1): 63-73. https://doi.org/10.1159/000322405. PMID: 21293134.
5. Lakhtakia S., Ramchandani M., Galasso D., Gupta R., Venugopal S., Kalpala R., Reddy D.N. EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos). Gastrointest. Endosc. 2016; 83 (1): 234-239. https://doi.org/10.1016/j.gie.2015.08.085. PMID: 26394384.
6. Chen O.T., Dojki F.K., Weber S.M., Hinshaw J.L. Percutaneous microwave ablation of an insulinoma in a patient with refractory symptomatic hypoglycemia. J. Gastrointest. Surg. 2015; 19 (7): 1378-1381. https://doi.org/10.1007/s11605-015-2831-2. PMID: 25941027.
7. Qin S.Y., Lu X.P., Jiang H.X. EUS-guided ethanol ablation of insulinomas: case series and literature review. Medicine (Baltimore). 2014; 93(14): e85. https://doi.org/10.1097/MD.0000000000000085. PMID: 25255024; PMCID: PMC4616284.
8. Bor R., Farkas K., Bálint A., Molnár T., Nagy F., Valkusz Z., Sepp K., Tiszlavicz L., Hamar S., Szepes Z. Endoscopic ultrasound-guided ethanol ablation: an alternative option for the treatment of pancreatic insulinoma. Orv. Hetil. 2014; 155 (41): 1647-1651. https://doi.org/10.1556/OH.2014.30012. PMID: 25282110.
9. Lee M.J., Jung C.H., Jang J.E., Hwang J.Y., Park D.H., Park T.S., Lee W.J. Successful endoscopic ultrasound-guided ethanol ablation of multiple insulinomas accompanied with multiple endocrine neoplasia type 1. Intern. Med. J. 2013; 43 (8): 948-950. https://doi.org/10.1111/imj.12208. PMID: 23919339.
10. Procházka V., Hlavsa J., Andrašina T., Starý K., Můčková K., Kala Z., Válek V. Laparoscopic radiofrequency ablation of functioning pancreatic insulinoma: video case report. Surg. Laparosc. Endosc. Percutan. Tech. 2012; 22 (5): e312-315. https://doi.org/10.1097/SLE.0b013e318264b607. PMID: 23047416.
11. Schnack C., Hansen C.Ø., Beck-Nielsen H., Mortensen P.M. Treatment of insulinomas with alcoholic ablation. Ugeskr. Laeger. 2012; 174 (8): 501-502. PMID: 22348674.
12. Levy M.J., Thompson G.B., Topazian M.D., Callstrom M.R., Grant C.S., Vella A. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest. Endosc. 2012; 75 (1): 200-206. https://doi.org/10.1016/j.gie.2011.09.019. PMID: 22078104.
13. Vleggaar F.P., Bij de Vaate E.A., Valk G.D., Leguit R.J., Siersema P.D. Endoscopic ultrasound-guided ethanol ablation of a symptomatic sporadic insulinoma. Endoscopy. 2011; 43 Suppl 2 UCTN:E328-9. https://doi.org/10.1055/s-0030-1256775. PMID: 22020710.
14. Akhlaghpoor S., Dahi F., Alinaghizadeh M., Shabestari A.A. CT fluoroscopy-guided transcaval radiofrequency ablation of insulinoma. J. Vasc. Interv. Radiol. 2011; 22 (3): 409-410. https://doi.org/10.1016/j.jvir.2010.10.031. PMID: 21277798.
15. Limmer S., Huppert P.E., Juette V., Lenhart A., Welte M., Wietholtz H. Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia. Eur. J. Gastroenterol. Hepatol. 2009; 21 (9): 1097-1101. PMID: 19685572.
16. Deprez P.H., Claessens A., Borbath I., Gigot J.F., Maiter D. Successful endoscopic ultrasound-guided ethanol ablation of a sporadic insulinoma. Acta Gastroenterol. Belg. 2008; 71 (3): 333-337. PMID: 19198582.
17. Jürgensen C., Schuppan D., Neser F., Ernstberger J., Junghans U., Stölzel U. EUS-guided alcohol ablation of an insulinoma. Gastrointest. Endosc. 2006; 63 (7): 1059-1062. PMID: 16733126.
18. Scott A., Hinwood D., Donnelly R. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma. Clin. Endocrinol. (Oxf.). 2002; 56 (4): 557-559. PMID: 11966750.
19. Martin R.C., Scoggins C.R., McMasters K.M. Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann. Surg. Oncol. 2010; 17 (1): 171-178. https://doi.org/10.1245/s10434-009-0686-z. PMID: 19707829.
20. Carrafiello G., Laganà D., Mangini M., Fontana F., Dionigi G., Boni L., Rovera F., Cuffari S., Fugazzola C. Microwave tumors ablation: principles, clinical applications and review of preliminary experiences. Int. J. Surg. 2008; 6 (Suppl 1): S65-69. https://doi.org/10.1016/j.ijsu.2008.12.028. PMID: 19186116.
21. Simon C.J., Dupuy D.E., Mayo-Smith W.W. Microwave ablation: principles and applications. Radiographics. 2005; 25 (Suppl 1): S69-83. PMID: 16227498.
22. Okabayashi T., Shima Y., Sumiyoshi T., Kozuki A., Ito S., Ogawa Y., Kobayashi M., Hanazaki K. Diagnosis and management of insulinoma. World J. Gastroenterol. 2013; 19 (6): 829-837. https://doi.org/10.3748/wjg.v19.i6.829. PMID: 23430217. PMCID: PMC3574879.
23. Chiruvella A., Kooby D.A. Surgical management of pancreatic neuroendocrine tumors. Surg. Oncol. Clin. N. Am. 2016; 25 (2): 401-421. https://doi.org/10.1016/j.soc.2015.12.002. PMID: 27013372.
24. Koshy A.A., Gordon I.O., Van Ha T.G., Kaplan E.L., Philipson L.H. Metastatic insulinoma following resection of nonsecreting pancreatic islet cell tumor: A case report and review of the literature. J. Investig. Med. High Impact Case Rep. 2013; 1 (1): 2324709612473274. https://doi.org/10.1177/2324709612473274. PMID: 26425568. PMC 4528785.
Review
For citations:
Chernousov A.F., Egorov A.V., Musaev G.Kh., Vasil'yev I.A., Parnova V.A., Yurichenko Yu.Yu., Lezhinsky D.V. Microwave Ablation of Insulinoma. Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2016;21(4):35-40. https://doi.org/10.16931/1995-5464.2016435-40
Views:
328
ISSN 1995-5464 (Print)
ISSN 2408-9524 (Online)
ISSN 2408-9524 (Online)
Email this article 